It is a metabolic condition
TMAU involves how the body processes a chemical compound. It is not contagious, and it is not caused by a person doing anything wrong.
About trimethylaminuria (TMAU)
Understanding TMAU, together.
TMAU is an uncommon metabolic condition. In simple terms, the body has difficulty changing a strongly smelling compound called trimethylamine (TMA) into a form with little or no odor.
This can affect a person’s breath, sweat, urine, and other body fluids. The impact is real, both physically and mentally, and nobody should have to navigate it alone.
This page is for education and support. It is not personal medical advice. A clinician and, when helpful, a registered dietitian can guide testing and care safely.
The essentials
What does TMAU mean in everyday life?
TMAU stands for trimethylaminuria. The name refers to trimethylamine (TMA), a compound made in the gut as food is processed. TMA has a powerful odor. Normally, the liver changes it into trimethylamine N-oxide (TMAO), which is much less noticeable and is passed out in urine.
Symptoms can vary
Odor can change over time and may be affected by diet, stress, hormones, illness, and the amount of TMA the body needs to process.
The social impact matters
Embarrassment, isolation, anxiety, and low mood can be part of the experience. Compassionate support is an important part of care.
The body’s pathway
From food to TMAO: where the process changes
This flow diagram shows how food is processed in the human body and where the FMO3 enzyme is involved in this process.
When the TMA-to-TMAO step is slowed or overwhelmed, more TMA can build up and be released in breath, sweat, urine, and other secretions.
Different routes, similar symptoms
Primary and secondary TMAU
TMAU is not one identical experience for every person. A clinical evaluation helps identify whether the body has an inherited FMO3-related difference or whether other factors may be affecting the same pathway.
Inherited form
Primary TMAU
Primary TMAU is linked to changes in the FMO3 gene. It is generally inherited in an autosomal recessive pattern. This means that a person received an altered copy of the gene from each parent.
FMO3 changes are not all the same, so enzyme activity and symptoms can vary from person to person.
Acquired or temporary forms
Secondary TMAU
Sometimes the body may be making more TMA than the usual process can handle, or the liver’s processing may be disrupted. This may be caused by dietary precursor overload with some liver, hormone, or illness-related factors as possible contributors.
Because different conditions can also produce odor symptoms, proper assessment is important before assuming a cause or choosing a management plan.
The human side of TMAU
A condition can be invisible, but still deeply felt.
The social and psychological burden of TMAU can be devastating. Many people carry the stress of anticipating others’ reactions, navigating school or work, or avoiding connection. Those experiences deserve to be taken seriously alongside the science.
Finding a clearer answer
How TMAU may be evaluated
Diagnosis should be guided by a qualified clinician. The goal is to understand what is happening, not to ask someone to prove or manage symptoms on their own.
-
Start with the full picture
A clinician can listen to symptom history, timing, health background, and other factors that may matter.
-
Use specialized urine testing when appropriate
The review describes laboratory analysis of TMA and TMAO, sometimes after a controlled challenge arranged by a care team.
-
Consider genetic testing
When biochemical results point to primary TMAU, genetic testing may help confirm an FMO3-related cause.
-
Build a personalized plan
Diagnosis can open the door to nutrition guidance, symptom support, and care that respects the person behind the test result.
Helpful questions for a medical appointment
Could another condition explain these symptoms? Would specialized urine testing make sense? How can nutrition stay adequate while identifying possible triggers? What mental health or peer support is available?
Care today, research tomorrow
What can help now and what is still being studied?
Established day-to-day management
Individualized, supported care
Personalized adjustment of dietary precursors and acidic soaps or lotions are common management approaches. Because choline is essential, nutrition changes should be made with clinical or dietitian support, not through a blanket elimination diet.
Discuss with a clinician
Care needs to fit the person
A care team can weigh medical history, nutrition, symptoms, and the possible harms of any intervention. Do not self-start antibiotics, supplements, or highly restrictive diets based on a list online.
Research under investigation
Currently, there's no cure
Researchers are studying gut-microbe approaches, ways to block bacterial TMA production, oral binding agents, and FMO3-focused therapies. However, much of this is still early-stage, small-scale, or preclinical.
Want more information?
Trusted government sources and peer-reviewed papers
The peer-reviewed paper by Schmidt & Leroux provides a great technical overview of the condition and the limited treatment approaches currently available. MedlinePlus provides official government information on the FMO3 gene and trimethylaminuria.
You can help change lives.
Your support fuels research, resources, and hope for people living with TMAU around the world.